{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:59:27Z","timestamp":1765979967193,"version":"3.48.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.semarthrit.2025.152837","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:30:59Z","timestamp":1758735059000},"page":"152837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comment on: \u201cDirect oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome\u201d"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3894-9698","authenticated-orcid":false,"given":"Venkata Dileep Kumar","family":"Veldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachana","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjana","family":"Sah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2025.152837_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152741","article-title":"Direct oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome: a systematic review and meta-analysis","volume":"73","author":"Celia","year":"2025","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152837_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101714","article-title":"A comparison of outcomes with apixaban, rivaroxaban, and warfarin for atrial fibrillation and\/or venous thromboembolism","volume":"4","author":"Schaefer","year":"2025","journal-title":"JACC Adv"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152837_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18549\/PharmPract.2023.2.2811","article-title":"Protocol for systematic review and meta-analysis on randomized clinical trials for direct oral anticoagulant in subjects with acute coronary syndrome","volume":"21","year":"2023","journal-title":"Pharm Pract (Granada)"},{"issue":"13","key":"10.1016\/j.semarthrit.2025.152837_bib0004","first-page":"3788","article-title":"Effectiveness and safety of apixaban in over 3.9 million people with atrial fibrillation: a systematic review and meta-analysis","volume":"11","author":"Buckley","year":"2022","journal-title":"Stomatology"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152837_bib0005","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.4244\/EIJ-D-23-00684","article-title":"Single antiplatelet therapy following Amplatzer left atrial appendage occlusion","volume":"20","author":"Kramer","year":"2024","journal-title":"EuroIntervention"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225002082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225002082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:55:13Z","timestamp":1765979713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225002082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":5,"alternative-id":["S0049017225002082"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152837","relation":{},"ISSN":["0049-0172"],"issn-type":[{"type":"print","value":"0049-0172"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on: \u201cDirect oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome\u201d","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152838","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152837"}}